Seegene Inc

Not Available for sale in the United States

  • Real-time
  • CE-IVD

Anyplex™ II
MTB/MDR Detection

Simultaneous detection of MTB and 25 mutations associated with MDR-TB using real-time PCR

Anyplex™II MTB/MDR Detection simultaneously detects and identifies Mycobacterium tuberculosis (MTB) and 25 mutations associated with MDR-TB. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instruments and provide prompt diagnosis and appropriate treatment guideline for tuberculosis control.



The results indicate the detection of MTB infection in the FAM channel, and the rifampicin-resistance mutation in the HEX channel and the Isoniazid-resistance mutation in the Cal Red 610 channel.


- Mycobacterium tuberculosis detection and drug susceptibility testing using Anyplex™ Real-time PCR in comparison with standard culture


[1] The WTC is designed to be exhibited the same result pattern with drug-susceptible M. tuberculosis sample. The WTC reaction should be always performed in each testing run, and the drug-resistant result of unknown samples is analyzed on the basis of the result of WTC.

[2] Multi-Drug Resistance